Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Myelination, oligodendrocytes, and serious mental illness.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Assessing relapse in multiple sclerosis questionnaire: results of a pilot study.
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.
Brain atrophy and lesion load predict long term disability in multiple sclerosis.
Multiple sclerosis: Regenerative therapies for MS-hope on the horizon.
The Nogo/ Nogo-66 receptor (NgR) signal is involved in neuroinflammation through the regulation of microglia inflammatory mediator expression.
Elevated Phospholipid Transfer Protein in Subjects with Multiple Sclerosis.
Pío del Río Hortega and the discovery of the oligodendrocytes.
"Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
Tumefactive multiple sclerosis requiring emergency craniotomy: Case report and literature review.
Demyelinating disease: CSF analysis could aid prediction of conversion from optic neuritis to multiple sclerosis in children.
Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis.
Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.
Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.
Analysis of CH25H in multiple sclerosis and neuromyelitis optica.
Regenerative Medicines for Remyelination: From Aspiration to Reality.
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
[Pulmonary lymphangioleiomyomatosis of unusual revelation during multiple sclerosis].
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters.
Monitoring game-based motor rehabilitation of patients at home for better plans of care and quality of life.
Pages
« first
‹ previous
…
526
527
528
529
530
531
532
533
534
…
next ›
last »